Hymenolepis

From WikiMD's WELLNESSPEDIA

Hymenolepis is a genus of cyclophyllid tapeworms responsible for the disease Hymenolepiasis. This genus includes two species that are notable parasites of humans, Hymenolepis nana and Hymenolepis diminuta.

Overview[edit]

The Hymenolepis genus belongs to the Cestoda class, a type of parasitic flatworms, commonly known as tapeworms. The members of this genus are characterized by their small size and the presence of multiple segments, or proglottids. They are typically found in the intestines of their hosts.

Species[edit]

The two species of Hymenolepis that are significant to human health are Hymenolepis nana and Hymenolepis diminuta.

Hymenolepis nana, also known as the dwarf tapeworm, is the most common tapeworm infection in humans worldwide. It is particularly prevalent in areas with poor sanitation and in individuals with close contact to rodents.

Hymenolepis diminuta, also known as the rat tapeworm, is less common in humans, with infections typically occurring in children and individuals who accidentally ingest infected insects, such as fleas or beetles.

Life Cycle[edit]

The life cycle of Hymenolepis species involves an intermediate host, which can be a variety of insects. The tapeworm eggs are ingested by the insect, and once inside, they develop into a larval stage. When the insect is eaten by a definitive host, such as a human or rodent, the larvae develop into adult tapeworms in the intestines.

Symptoms and Treatment[edit]

Infection with Hymenolepis species can be asymptomatic, but can also cause symptoms such as abdominal pain, diarrhea, and weight loss. The diagnosis is typically made by identifying tapeworm eggs in a stool sample.

Treatment for Hymenolepis infection involves anti-parasitic medications, such as praziquantel or niclosamide. Prevention strategies include good hygiene practices and pest control.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.